CATANIA, Italy, July 30 /PRNewswire-FirstCall/ — The
partners in a new publicly-funded European research project today
announced details of the multinational/multidisciplinary program:
‘CSI: Central Nervous System Imaging.’ This three-year ENIAC
(European Nanoelectronics Initiative Advisory Council) project aims
to achieve substantial advances in state-of-the-art medical
3D-imaging platforms by focusing on the diagnosis and therapy of
serious diseases of the central nervous system and brain. Key
medical-imaging technologies will be significantly enhanced by
means of major improvement in sensors, equipment and computing
platforms to boost early diagnostics and prevention capability
while reducing total equipments cost.
One of the most important challenges facing Europe is the trend towards an aging
population. With many of the elderly people suffering from diseases
of the central nervous system, the number of patients is also
growing. These serious illnesses require some of the most expensive
diagnosis/therapy procedures. In addition, these diseases, which
include degenerative brain diseases such as Alzheimer’s and
Parkinson’s diseases, Epilepsy, and circulatory problems such as
strokes, are among those with the fastest growing impact on
society.
Minimally-invasive ICT-based imaging technologies such as PET
(Positron Emission Tomography), MRI (Magnetic Resonance Imaging)
and EEG (Electro EncephaloGraphy) play a vital role in detecting
and tracking the evolution of these illnesses and determining the
strategy and the effectiveness of the prescribed therapies. Part of
the ENIAC ‘Nanoelectronics for Health and Wellness’ sub-program,
the CSI project will pursue the simultaneous capturing/extraction
of data produced by next-generation imaging devices in order to
provide the best correlated inform
‘/>”/>
